Trend

Last Previous Currency Date Chng
50.19 48.75 USD 26/06/11 +2.95

Terms

Isin LU0122613499
Contract Type Sicav
Currency USD
Class N
Risk Class 5
Assogestioni Category Azionari Salute
Declared Benchmark 100% Nasdaq Biotech
Start Date 00/12/29
Advisor Name Evan McCulloch; Vincent Xiang
Fund Asset Under Management N.Av.

Performance

Cumulatives
1 month -1.19
Ytd +5.35
1 year +57.20
3 years +66.54
5 years +42.68
Yearly
05/31/2025 +32.61
05/31/2024 +8.37
05/31/2023 +12.38
05/31/2022 -7.81
05/31/2021 -11.12
Rating
Score
81.609

Company

Franklin Templeton Int. Serv.
8A, rue Albert Borschette L-1246 - LUXEMBOURG
Tel. N.Av.

Costs

Entrance (ACP) Min: 3,0000 - Max: 3,0000
Management 2.25
Reimbursement 0%
Administrative 0%
Switch 0%
Tunnel 0

Subscription

One Solution
Initial 2500,0000 USD
Integrative 500,0000 USD
Accumulation Plan
Duration N.Av.
Minimum Payment Unit N.Av.
Initial Payment 2500,0000

Costs

Entrance (ACP) Min: 3,0000 - Max: 3,0000
Management 2.25
Reimbursement 0%
Administrative 0%
Switch 0%
Tunnel 0

Performance

Cumulatives
1 day +2.97
1 week +0.63
1 month -1.19
3 months +1.78
6 months +3.77
From the beginning of the year +5.35
1 year +57.20
2 years +35.97
3 years +66.54
4 years +96.99
5 years +42.68
Yearly
05/31/2025 +32.61
05/31/2024 +8.37
05/31/2023 +12.38
05/31/2022 -7.81
05/31/2021 -11.12


Rating
Rating Rating Rating Rating Rating
Score
81.609

Efficiency Indicators

Sharpe 1 year 2.1325
Benchmark 1 year N.Av.
Sharpe 3 years 0.7782
Benchmark 3 years N.Av.
Sharpe 5 years 0.3604
Benchmark 5 years N.Av.
Sortino 1 year 10.4995
Benchmark 1 year N.Av.
Sortino 3 years 1.6496
Benchmark 3 years N.Av.
Sortino 5 years 0.65
Benchmark 5 years N.Av.

Absolute

Standard Volatility
1 year +21.84
3 years +20.74
5 years +19.52
Negative Volatility
1 year +4.44
3 years +9.80
5 years +10.75

Benchmark

Standard Volatility
1 year N.Av.
3 years N.Av.
5 years N.Av.
Negative Volatility
1 year N.Av.
3 years N.Av.
5 years N.Av.
Updated Monthly - 26/05/29

Relative

Sharpe 0.7782
Sortino 1.6496
Bull Market +10.68
Bear Market -4.13
Benchmark N.Av.
Benchmark N.Av.
Benchmark N.Av.
Benchmark N.Av.
Three years data
Risk Class 5

General

  1 year 17,946 3 years 15,848 5 years 14,193
  Pos. Chng % Pos. Chng % Pos. Chng %
Performance
1 year 17,946
445
  
+68.29
3 years 15,848
1,596
  
+74.07
5 years 14,193
2,592
  
+57.91
Performance
445 +68.29 1,596 +74.07 2,592 +57.91
Total Volatility
1 year 17,946
21,062
  
+21.84
3 years 15,848
18,641
  
+20.74
5 years 14,193
16,009
  
+19.52
Total Volatility
21,062 +21.84 18,641 +20.74 16,009 +19.52
Negative Volatility
1 year 17,946
9,893
  
+4.44
3 years 15,848
16,659
  
+9.80
5 years 14,193
14,190
  
+10.75
Negative Volatility
9,893 +4.44 16,659 +9.80 14,190 +10.75
Sharpe Index
1 year 17,946
1,224
  
+2.13
3 years 15,848
5,531
  
+0.78
5 years 14,193
5,279
  
+0.36
Sharpe Index
1,224 +2.13 5,531 +0.78 5,279 +0.36
Sortino Index
1 year 17,946
305
  
+10.50
3 years 15,848
3,160
  
+1.65
5 years 14,193
4,284
  
+0.65
Sortino Index
305 +10.50 3,160 +1.65 5,279 +0.65

By Category

  1 year 17,946 3 years 15,848 5 years 14,193
  Pos. Chng % Pos. Chng % Pos. Chng %
Performance
1 year 17,946
7
  
+68.29
3 years 15,848
3
  
+74.07
5 years 14,193
11
  
+57.91
Performance
7 +68.29 3 +74.07 11 +57.91
Total Volatility
1 year 17,946
115
  
+21.84
3 years 15,848
99
  
+20.74
5 years 14,193
78
  
+19.52
Total Volatility
115 +21.84 99 +20.74 78 +19.52
Negative Volatility
1 year 17,946
13
  
+4.44
3 years 15,848
26
  
+9.80
5 years 14,193
53
  
+10.75
Negative Volatility
13 +4.44 26 +9.80 53 +10.75
Sharpe Index
1 year 17,946
7
  
+2.13
3 years 15,848
9
  
+0.78
5 years 14,193
12
  
+0.36
Sharpe Index
7 +2.13 9 +0.78 12 +0.36
Sortino Index
1 year 17,946
9
  
+10.50
3 years 15,848
2
  
+1.65
5 years 14,193
12
  
+0.65
Sortino Index
9 +10.50 2 +1.65 12 +0.65

Foreign Funds - Franklin Biotechnology Discovery N $: Performance, Terms, Fees, Risk, Rating


The Exchange accepts no responsability for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.


You will be redirected in five seconds.